Clinical and Experimental Reproductive Medicine-CERM

metrics 2024

Elevating Standards in Clinical and Experimental Reproductive Medicine

Introduction

Clinical and Experimental Reproductive Medicine (CERM) is a premier journal dedicated to advancing the field of reproductive medicine. Published by the Korean Society of Reproductive Medicine, it aims to disseminate high-quality research and innovative clinical practices in reproductive health and medicine. With its Q3 ranking in reproductive medicine for 2023, CERM is positioned as a significant resource for researchers and practitioners seeking to stay current with the latest developments and findings in the field. Since its inception in 2011, CERM has provided a vital platform for original research articles, review papers, and case studies that cover a range of topics, including fertility treatments, reproductive endocrinology, and embryology. Researchers benefit from its accessibility, inspiring new insights and evidence-based approaches to clinical practices. Based in South Korea, its rigorous peer-reviewed publication process ensures that all contributions meet high academic standards, making it an invaluable asset for anyone engaged in reproductive health research or practice.

Metrics 2024

SCIMAGO Journal Rank0.49
Journal Impact Factor1.80
Journal Impact Factor (5 years)1.90
H-Index32
Journal IF Without Self1.80
Eigen Factor0.00
Normal Eigen Factor0.14
Influence0.43
Immediacy Index0.20
Cited Half Life5.80
Citing Half Life8.10
JCI0.57
Total Documents451
WOS Total Citations695
SCIMAGO Total Citations2031
SCIMAGO SELF Citations71
Scopus Journal Rank0.49
Cites / Document (2 Years)1.94
Cites / Document (3 Years)1.98
Cites / Document (4 Years)2.11

Metrics History

Rank 2024

Scopus

Reproductive Medicine in Medicine
Rank #43/90
Percentile 52.22
Quartile Q2

IF (Web Of Science)

OBSTETRICS & GYNECOLOGY
Rank 72/136
Percentile 47.40
Quartile Q3
REPRODUCTIVE BIOLOGY
Rank 30/39
Percentile 24.40
Quartile Q4

JCI (Web Of Science)

OBSTETRICS & GYNECOLOGY
Rank 88/136
Percentile 35.29
Quartile Q3
REPRODUCTIVE BIOLOGY
Rank 30/39
Percentile 23.08
Quartile Q4

Quartile History

Similar Journals

JOURNAL OF REPRODUCTION AND DEVELOPMENT

Exploring the intricate pathways of life.
Publisher: SOCIETY REPRODUCTION & DEVELOPMENT-SRDISSN: 0916-8818Frequency: 6 issues/year

JOURNAL OF REPRODUCTION AND DEVELOPMENT, published by the SOCIETY REPRODUCTION & DEVELOPMENT-SRD in Japan, is a leading peer-reviewed journal dedicated to advancing the field of reproduction and development in animal sciences. With a notable impact factor reflected in its prestigious Q1 Quartile ranking in Animal Science and Zoology, the journal aims to disseminate cutting-edge research that explores the complexities of reproductive biology, developmental processes, and their implications for agriculture and biodiversity. This journal invites contributions that span multidisciplinary interests, thereby facilitating the integration of scientific knowledge and practical applications. Researchers, professionals, and students can benefit from the insights shared within its pages, as it strives to foster collaboration and innovation in the field. The journal’s comprehensive scope and esteemed reputation, underscored by its Scopus rank of #115 out of 490 in the category, make it an invaluable resource for anyone invested in the study of reproduction and development.

World Journal of Mens Health

Transforming men's health through impactful scholarship.
Publisher: KOREAN SOC SEXUAL MEDICINE & ANDROLOGYISSN: 2287-4208Frequency: 4 issues/year

World Journal of Men's Health, published by the Korean Society for Sexual Medicine and Andrology, stands at the forefront of research in urology, reproductive medicine, and public health. This open-access journal, which has been serving the global medical community since 2011, provides a platform for high-quality, peer-reviewed articles spanning various disciplines, including aging, health policy, and pharmacology. With impressive rankings in multiple categories—such as Q1 in Urology and Q2 in Reproductive Medicine—the journal is recognized for its impactful contributions to advancing knowledge and practice. The ISSN 2287-4208 and E-ISSN 2287-4690 ensure its broad visibility and accessibility. The journal's commitment to disseminating vital research findings makes it an essential resource for researchers, practitioners, and students dedicated to improving men's health worldwide. With its editorial office located at Pusan National University Medical School, Dept of Urology, Busan, South Korea, it continues to enrich the academic and clinical landscape.

SEMINARS IN REPRODUCTIVE MEDICINE

Transforming Perspectives in Obstetrics and Gynecology
Publisher: THIEME MEDICAL PUBL INCISSN: 1526-8004Frequency: 6 issues/year

SEMINARS IN REPRODUCTIVE MEDICINE is a leading peer-reviewed journal dedicated to exploring the complexities of human reproduction, offering insightful perspectives that encompass advances in reproductive endocrinology, obstetrics, and gynecology. Published by THIEME MEDICAL PUBL INC, this esteemed journal holds a notable spot in multiple Scopus categories, ranking 21st in Reproductive Medicine and 38th in Obstetrics and Gynecology, with an impressive impact in the Q1 and Q2 quartiles. With its commitment to high-quality research and clinical implications, the journal serves as a vital resource for practitioners, researchers, and students alike, fostering an environment of innovation and collaboration in the rapidly evolving reproductive health landscape. SEMINARS IN REPRODUCTIVE MEDICINE also offers convenient open access options, ensuring that its contributions are readily available to the global academic community. For over two decades, from its establishment in 1999 to the present, it has retained a pivotal role in disseminating critical findings that inform both clinical practice and future research efforts.

REPRODUCTIVE BIOMEDICINE ONLINE

Fostering excellence in reproductive medicine and scientific discourse.
Publisher: ELSEVIER SCI LTDISSN: 1472-6483Frequency: 14 issues/year

Reproductive Biomedicine Online, published by Elsevier, is a leading peer-reviewed journal that has established itself as a pivotal resource in the fields of Developmental Biology, Obstetrics and Gynecology, and Reproductive Medicine. With an impressive Impact Factor and a Q1 ranking in its respective disciplines as of 2023, this journal provides a platform for innovative research and comprehensive reviews that contribute to advancements in reproductive healthcare. The journal boasts rigorous Scopus rankings, placing it within the top tiers of its categories, which underscores its significance in shaping contemporary biomedical inquiry. Although not open access, it remains widely accessible through institutional subscriptions, making its wealth of knowledge available to researchers, clinicians, and students alike. Since its inception in 2000, Reproductive Biomedicine Online has been committed to fostering a deeper understanding of reproductive processes and biomedicine, ensuring that its content remains relevant and impactful in addressing challenges in reproductive health, thereby championing exceptional scientific discourse.

Reproductive Biology and Endocrinology

Pioneering Insights in Reproductive and Endocrine Health
Publisher: BMCISSN: Frequency: 1 issue/year

Reproductive Biology and Endocrinology, published by BMC, is a distinguished open-access journal established in 2003, catering to researchers and professionals in the interdisciplinary fields of reproductive biology, endocrinology, and related biomedical sciences. With a notable impact in 2023, the journal has achieved Q1 rankings in Obstetrics and Gynecology, Reproductive Medicine, and Endocrinology, alongside a Q2 ranking in Developmental Biology, establishing itself as a pivotal source of high-quality research and insights. The journal's commitment to freely accessible research promotes knowledge dissemination across its domains, which is crucial for advancing understanding of reproductive health and endocrine mechanisms. With a robust Scopus ranking showcasing its relevance—17th out of 209 in Obstetrics and Gynecology, and 8th out of 90 in Reproductive Medicine—it serves as an essential resource for academics and clinicians alike, facilitating innovative research and fostering collaboration within the global scientific community.

Reproduction and Fertility

Innovating research in reproductive medicine.
Publisher: BIOSCIENTIFICA LTDISSN: Frequency:

Reproduction and Fertility is a premier academic journal published by BIOSCIENTIFICA LTD, dedicated to advancing knowledge in the fields of reproductive sciences, obstetrics, gynecology, and related areas. Established with a focus on delivering high-quality research, this journal has quickly ascended in prominence, achieving a commendable Q2 ranking in multiple categories, including Embryology, Obstetrics and Gynecology, Reproductive Medicine, and Urology, as of 2023. With an E-ISSN of 2633-8386, Reproduction and Fertility aims to provide a valuable platform for researchers, professionals, and students alike, offering insights into the latest discoveries and innovations in reproductive health. Although currently not an open-access journal, it remains committed to disseminating important findings that can influence clinical practices and policy-making worldwide. Operating from its headquarters in Bristol, United Kingdom, the journal serves as an essential resource for anyone invested in understanding and improving reproductive health outcomes through rigorous academic research.

Asian Pacific Journal of Reproduction

Bridging Gaps in Reproductive Knowledge
Publisher: WOLTERS KLUWER MEDKNOW PUBLICATIONSISSN: 2305-0500Frequency: 6 issues/year

Asian Pacific Journal of Reproduction is a dynamic open-access journal specializing in a diverse array of topics related to reproduction across various species, including humans, animals, and plants. Published by Wolters Kluwer Medknow Publications, this peer-reviewed journal has been committed to disseminating high-quality research since its inception in 2012. With an accessible ISBN of 2305-0500 and E-ISSN 2305-0519, the journal has rapidly established itself within the academic community, evidenced by its categorization in Q3 and Q4 quartiles across multiple fields, including Obstetrics, Gynecology, and Animal Science. Researchers are encouraged to contribute their findings to foster a deeper understanding of reproductive health and practices in the Asian Pacific region and beyond. The journal's inclusive scope and emphasis on interdisciplinary collaboration make it a crucial platform for professionals and scholars seeking to stay at the forefront of reproductive research.

GYNECOLOGICAL ENDOCRINOLOGY

Innovating Solutions for Gynecological Endocrinology
Publisher: TAYLOR & FRANCIS LTDISSN: 0951-3590Frequency: 12 issues/year

GYNECOLOGICAL ENDOCRINOLOGY is a prestigious open-access journal published by Taylor & Francis Ltd, focusing on the dynamic fields of endocrinology, obstetrics, and gynecology. With its ISSN of 0951-3590 and E-ISSN of 1473-0766, this journal provides a vital platform for the dissemination of high-quality research and advancements in gynecological endocrinology since its inception in 1987. Notably, it attained an Open Access status in 2023, enhancing its reach and accessibility to researchers and practitioners worldwide. The journal is renowned for its rigorous peer-review process and holds significant standing with a Q2 ranking in Obstetrics and Gynecology and a Q3 ranking in Endocrinology, Diabetes, and Metabolism, as of 2023. It is indexed with commendable Scopus ranks in various medical domains, offering a reliable resource for current methodologies and future directions in gynecological health. With the growing emphasis on women's health and endocrinological research, GYNECOLOGICAL ENDOCRINOLOGY serves as an essential repository for innovative studies, clinical insights, and emerging therapeutic strategies, making it an invaluable resource for researchers, clinicians, and students alike.

Basic and Clinical Andrology

Bridging science and practice for a healthier future in andrology.
Publisher: BMCISSN: Frequency: 1 issue/year

Basic and Clinical Andrology, published by BMC, is a leading open access journal dedicated to the advancement of knowledge in the field of reproductive medicine and urology. Since its launch in 2013, the journal has aimed to provide a platform for the dissemination of high-quality research, bridging the gap between basic science and clinical practice. With an impressive reputation evidenced by its Q2 ranking in both reproductive medicine and urology, it serves as a vital resource for researchers, healthcare professionals, and students looking to stay updated on the latest developments in andrology. The journal actively encourages submissions across a diverse range of topics, contributing to our understanding of male reproductive health issues, advancements in treatment protocols, and innovative therapeutic approaches. Located in the United Kingdom, Basic and Clinical Andrology plays a critical role in the global discourse on andrology, offering researchers an opportunity to share their findings with a broad audience committed to improving health outcomes in these crucial fields.

Journal of the Endocrine Society

Connecting researchers and practitioners in the realm of hormones.
Publisher: ENDOCRINE SOCISSN: Frequency: 12 issues/year

Journal of the Endocrine Society, published by the ENDOCRINE SOC, stands as a prominent platform for disseminating significant research and findings within the field of endocrinology, diabetes, and metabolism. Established as an Open Access journal since 2017, it aims to increase the visibility and accessibility of vital scholarly contributions, allowing researchers and professionals from various backgrounds to engage with the latest insights in this rapidly evolving discipline. With an impressive Q2 ranking in Endocrinology, Diabetes and Metabolism, the journal is recognized for its impact, ranking #100 out of 244 in Scopus, highlighting its role in advancing scientific knowledge and fostering innovation. The journal, based in the United States at 2055 L ST NW, SUITE 600, WASHINGTON, DC 20036, continues to enrich the academic landscape by converging state-of-the-art research and clinical applications through its publication cycle from 2017 to 2024. Researchers, students, and healthcare professionals are encouraged to explore this essential resource to stay at the forefront of endocrinological advancements.